Friday, October 5, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall
Tracks: Adult ID, Epidemiology and Infection Control, Investigative ID, Pediatric ID
Presentations:
Molecular epidemiology, serotype distribution, antimicrobial sensitivity and clinical findings of adult pneumococcal pneumonia patients in Japan; hospital-based study
Satoshi Kakiuchi, M.D.;
Motoi Suzuki, M.D., Ph.D.;
Christopher M. Parry, M.D., Ph.D.;
Michio Yasunami, M.D., Ph.D.;
Konosuke Morimoto, M.D., Ph.D.
Impact of Mental Illness on Outcomes of Outpatients with Community Acquired Pneumonia
Kari Mergenhagen, Pharm.D., BCPS AQ-ID;
Megan Skelly, PharmD;
Bethany Wattengel, PharmD;
Randal Napierala, PharmD;
John Sellick, D.O., M.S., FIDSA, FSHEA;
Jennifer Schroeck, PharmD
Ninety-one Day Quality of Life Post-Pneumonia Diagnosis in Adult Patients in Japan
Henry Glick, PhD;
Taiga Miyazaki, M.D., Ph.D.;
Katsuji Hirano, MD;
Jose Suaya, MD, PhD;
Elisa Gonzalez, MS;
Bradford D. Gessner, MD;
Raul E. Isturiz, MD;
Adriano G. Arguedas, MD;
Shigeru Kohno, MD
Biomarkes in Different Etiologies of Pneumonia in Pediatrics in Indonesia
Dewi Lokida, MD, Clinical Pathologist;
Nurhayati Nurhayati, MD, M.Epid;
Arif Budiman, MD, Pediatrician;
Helmia Farida, MD, PhD, Pediatrician;
Moh Syarofil Anam, MD, MSi.Med, Pediatrician;
Muhammad Rosyid Ridho, MD;
Isabella Puspa Dewi, MD;
Mochamad Helmi Aziz, MD, MSc;
Herman Kosasih, MD, PhD;
Muhammad Karyana, MD, M.Kes
Non-Invasive Pneumococcal Pneumonia in the United States, 2013–2014
Almea Matanock, MD;
Ryan Gierke, MPH;
Nong Shang, PhD;
James Watt, MD, MPH;
Nisha Alden, MPH;
Susan Petit, MPH;
Monica M. Farley, MD, FIDSA;
Lee H. Harrison, MD;
Katherine Schleiss, MPH;
Kari Burzlaff, MPH;
Ann Thomas, MD, MPH;
William Schaffner, MD, FIDSA, FSHEA;
Gayle E. Langley, MD, MPH;
Tamara Pilishvili, MPH, PhD
Discovering Outpatient Stewardship Targets: An Evaluation of Community Acquired Pneumonia in the Outpatient Setting
Bethany Wattengel, PharmD;
Kari Mergenhagen, Pharm.D., BCPS AQ-ID;
John Sellick, D.O., M.S., FIDSA, FSHEA;
Jennifer Schroeck, PharmD;
Megan Skelly, PharmD;
Randal Napierala, PharmD
Clinical Significance of Microbiologic Treatment Failure following Clinical Cure of Pneumonia.
Owen Albin, MD;
Oryan Henig, MD;
Twisha S. Patel, PharmD, BCPS;
Jason M. Pogue, PharmD, BCPS-AQ ID;
Lindsay Petty, MD;
Thomas Valley, MD;
John P. Mills, MD;
Keith Kaye, MD, MPH
PCV13 Serotype Trends Over Time in Pneumococcal Community Acquired Pneumonia: Which Method(s) Work Best?
Jason Leblanc, PhD;
May Elsherif, MD;
Lingyun Ye, MSc;
Donna Mackinnon-Cameron, MMath;
Ardith Ambrose, RN;
Todd Hatchette, MD FRCPC;
Irene Martin, BSc;
Melissa K Andrew, MD, PhD;
Guy Boivin, MD, MSc;
William R. Bowie, MD, FRCPC, FIDSA;
Karen Green, MSc, RN;
Jennie Johnstone, MD, PhD;
Mark Loeb, MD, MSc;
Anne Mccarthy, MD, MSc;
Allison McGeer, MD, MSc;
Makeda Semret, MD;
Sylvie Trottier, MD, PhD;
Louis Valiquette, MD, MSc, FRCPC;
Duncan Webster, MD;
Shelly A McNeil, MD, FIDSA
Neurocognitively-Acting Potentially Inappropriate Medications, Alcohol, and Community-Acquired Pneumonia among Patients with and without HIV
Christopher T. Rentsch, MPH;
Janet P. Tate, MPH, ScD;
Kirsha S. Gordon, PhD;
Alice Tseng, PharmD;
Kristina M. Niehoff, PharmD;
Kristina A. Crothers, MD;
E. Jennifer Edelman, MD;
Amy C. Justice, MD, PhD
CME Credits: Maximum of 0.00 hours of
AMA PRA Category 1 Credit™
